Table II.
Variable | Overall | Q1 (highest benefit) |
Q2 (moderate benefit) |
Q3 (low benefit) |
Q4 (questionable benefit) |
P value |
---|---|---|---|---|---|---|
Limbs treated, No. | 187 (100) | 51 (27.3) | 59 (31.6) | 38 (20.3) | 39 (20.9) | NA |
WIfI stage | <.001 | |||||
1 | 12 (6.4) | 0 (0) | 0 (0) | 11 (29.0) | 1 (2.6) | |
2 | 18 (9.6) | 0 (0) | 7 (11.9) | 9 (23.7) | 2 (5.1) | |
3 | 45 (24.1) | 18 (35.3) | 10 (17.0) | 16 (42.1) | 1 (2.6) | |
4 | 112 (59.9) | 33 (64.7) | 42 (71.2) | 2 (5.3) | 35 (89.7) | |
Revascularization approach | .09 | |||||
Endovascular | 125 (66.8) | 37 (72.6) | 32 (54.2) | 29 (76.3) | 27 (69.2) | |
Open surgery | 62 (33.2) | 14 (27.5) | 27 (45.8) | 9 (23.7) | 12 (30.8) |
NA, Not applicable; Q, quartile; WIfI, Wound, Ischemia, and foot Infection.
Data presented as number (%).